Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 9 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kiora Pharmaceuticals Inc | KPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.545 | 05:57:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.545 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 3 | 9 | - | 0.4622 - 8.515 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 05:44:47 | 1 | $ 0.54 | USD |
Kiora Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.15M | 7.69M | - | 0 | -13.58M | -1.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kiora Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.506 | 0.55 | 0.475 | 0.5238197 | 73,211 | 0.039 | 7.71% |
| 1 Month | 0.70 | 0.73 | 0.475 | 0.6277685 | 194,034 | -0.155 | -22.14% |
| 3 Months | 0.53 | 0.73 | 0.475 | 0.6069038 | 108,066 | 0.015 | 2.83% |
| 6 Months | 0.839 | 0.9099 | 0.4622 | 0.6417343 | 259,180 | -0.294 | -35.04% |
| 1 Year | 3.65 | 8.515 | 0.4622 | 4.29 | 535,174 | -3.11 | -85.07% |
| 3 Years | 2.03 | 10.39 | 0.1215 | 1.18 | 2,044,264 | -1.49 | -73.15% |
| 5 Years | 2.03 | 10.39 | 0.1215 | 1.18 | 2,044,264 | -1.49 | -73.15% |
Kiora Pharmaceuticals Description
| Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. It operates in one reportable segment operations and manages. |
